Long noncoding RNA X‐inactive specific transcript (lncRNA XIST) inhibits hepatic insulin resistance by competitively binding microRNA‐182‐5p
Immunity, Inflammation and Disease · 2023-11 · 11 (11)
DOI: 10.1002/iid3.969 ↗Kurz gefasst
Fachartikel in der Zeitschrift Immunity, Inflammation and Disease, online erschienen am 07.11.2023. Verfasst von Guoqing Zhong und 5 weiteren Autor:innen. Beteiligte Einrichtung: Hepatology Department, First People's Hospital, Nanyang, China. Hauptthemen laut MEDLINE: Insulin Resistance, MicroRNAs, RNA, Long Noncoding, Hepatocytes. Die Arbeit wurde bisher 5-mal zitiert (Crossref) und nennt 39 Literaturangaben. Der Volltext ist frei zugänglich (Open Access, CC BY 4.0).
Abstract (Originalsprache)
Background
What is highlighted in this study refers to the role and molecular mechanism of long noncoding RNA (lncRNA) X‐inactive specific transcript (XIST) in cells with insulin resistance (IR).
Methods
In this study, LX‐2 cells were applied to establish IR model in vitro. The expressions of lncRNA XIST, phosphoenolpyruvate carboxykinase (PEPCK,) and glucose‐6‐phosphatase (G6Pase) were quantified by quantitative reverse transcription polymerase chain reaction. The 2‐deoxy‐ d ‐glucose‐6‐phosphate (2‐DG6P) level was detected utilizing 2‐deoxy‐d‐glucose (2‐DG) uptake measurement kit. Western blot was adopted to measure the protein expressions of insulin‐like growth factor‐1 receptor (IGF‐1R), G6Pase, PEPCK, and phosphatidylinositol 3‐kinase (PI3K)/Akt pathway‐related genes. StarBase was used to predict the targeting relationship between lncRNA XIST or IGF‐1R with miR‐182‐5p, the results of which were verified by dual‐luciferase reporter, RNA pull‐down, and RNA immunoprecipitation assays. Rescue experiments were conducted to investigate the effect of miR‐182‐5p on IR cells. Next, low‐expressed lncRNA XIST and high‐expressed miR‐182‐5p were observed in IR cells.
Results
Upregulation of lncRNA XIST increased IGF‐1R and 2‐DG6P levels, decreased G6Pase and PEPCK expressions, and promoted PI3K/Akt pathway activation in IR cells. LncRNA XIST sponged miR‐182‐5p which targeted IGF‐1R. MiR‐182‐5p mimic reversed the above effects of lncRNA XIST overexpression on IR cells.
Conclusions
In conclusion, lncRNA XIST/miR‐182‐5p axis alleviates hepatic IR in vitro via IGF‐1R/PI3K/Akt signaling pathway, which could be the promising therapeutic target.
Schlagwörter
MeSH-Schlagwörter (MEDLINE)
Stichwörter der Autor:innen
Substanzen
Autor:innen und Institutionen
- Hepatology Department, First People's Hospital, Nanyang, China.
- Endocrinology Department, First People's Hospital, Nanyang, China.
ORCID-Profile: Qingping Yang
Zitieren
APA
Zhong, G., Yang, Q., Wang, Y., Liang, Y., Wang, X., & Zhao, D. (2023). Long noncoding RNA X‐inactive specific transcript (lncRNA XIST) inhibits hepatic insulin resistance by competitively binding microRNA‐182‐5p. Immunity, Inflammation and Disease, 11(11). https://doi.org/10.1002/iid3.969
Vancouver
Zhong G, Yang Q, Wang Y, Liang Y, Wang X, Zhao D. Long noncoding RNA X‐inactive specific transcript (lncRNA XIST) inhibits hepatic insulin resistance by competitively binding microRNA‐182‐5p. Immunity, Inflammation and Disease. 2023;11(11). doi:10.1002/iid3.969
BibTeX
@article{Zhong2023,
author = {Zhong, Guoqing and Yang, Qingping and Wang, Yihua and Liang, Yuan and Wang, Xiaojing and Zhao, Dongli},
title = {Long noncoding RNA X‐inactive specific transcript (lncRNA XIST) inhibits hepatic insulin resistance by competitively binding microRNA‐182‐5p},
journal = {Immunity, Inflammation and Disease},
year = {2023},
volume = {11},
number = {11},
doi = {10.1002/iid3.969}
}
EUVIMED